Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) ...

New treatment option: FDA approved Zepbound in 2024 as the first drug specifically for obstructive sleep apnea in adults with obesity. Study-backed benefits: A JAMA study found GLP-1 users were less ...

These are trying times for the health care technology industry, but a turnaround may be on the way for investors who have patience. The benchmark Global X HealthTech ETF (ticker: ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 1:00 PM EDTCompany ParticipantsJames Bradner - Executive Vice President ...

The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the category; Randomized contr ...

The US President is desperate for a win. China is thinking about the next century ...

Pfizer’s first quarter results reflected continued momentum in its core portfolio, with management attributing growth to ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...

Alnylam Stock Soars 65%: Find Out What's Behind the Gains Alnylam Pharmaceuticals (NASDAQ:ALNY) Chief Financial Officer Jeff Poulton said the company remains confident in its TTR revenue guidance ...

Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement ...

The death rate from cancer in the United States has fallen by more than one-third since 1991. HIV-related mortality has dropped ninefold since 1995. Death rates for Alzheimer's, chronic respiratory ...